Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Improved genome editing by an engineered CRISPR-Cas12a

Journal Article · · Nucleic Acids Research
DOI:https://doi.org/10.1093/nar/gkac1192· OSTI ID:2470693

CRISPR-Cas12a is an RNA-guided, programmable genome editing enzyme found within bacterial adaptive immune pathways. Unlike CRISPR-Cas9, Cas12a uses only a single catalytic site to both cleave target double-stranded DNA (dsDNA) (cis-activity) and indiscriminately degrade single-stranded DNA (ssDNA) (trans-activity). To investigate how the relative potency of cis- versus trans-DNase activity affects Cas12a-mediated genome editing, we first used structure-guided engineering to generate variants of Lachnospiraceae bacterium Cas12a that selectively disrupt trans-activity. The resulting engineered mutant with the biggest differential between cis- and trans-DNase activity in vitro showed minimal genome editing activity in human cells, motivating a second set of experiments using directed evolution to generate additional mutants with robust genome editing activity. Notably, these engineered and evolved mutants had enhanced ability to induce homology-directed repair (HDR) editing by 2–18-fold compared to wild-type Cas12a when using HDR donors containing mismatches with crRNA at the PAM-distal region. Finally, a site-specific reversion mutation produced improved Cas12a (iCas12a) variants with superior genome editing efficiency at genomic sites that are difficult to edit using wild-type Cas12a. This strategy establishes a pipeline for creating improved genome editing tools by combining structural insights with randomization and selection. The available structures of other CRISPR-Cas enzymes will enable this strategy to be applied to improve the efficacy of other genome-editing proteins.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE; National Science Foundation (NSF); National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
2470693
Journal Information:
Nucleic Acids Research, Journal Name: Nucleic Acids Research Journal Issue: 22 Vol. 50; ISSN 0305-1048
Publisher:
Oxford University PressCopyright Statement
Country of Publication:
United States
Language:
English

References (39)

The bridge helix of Cas12a imparts selectivity in cis‐DNA cleavage and regulates trans‐DNA cleavage journal February 2021
Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA journal May 2016
Conformational Activation Promotes CRISPR-Cas12a Catalysis and Resetting of the Endonuclease Activity journal December 2018
Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a journal April 2017
Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a journal February 2019
Mechanistic insights into the versatile class II CRISPR toolbox journal May 2022
Engineered CRISPR-Cas9 nucleases with altered PAM specificities journal June 2015
The crystal structure of Cpf1 in complex with CRISPR RNA journal April 2016
Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage journal May 2017
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition journal November 2015
Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells journal June 2016
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells journal June 2016
Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array journal December 2016
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes journal February 2017
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain journal December 2009
CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA journal March 2018
Direct observation of DNA target searching and cleavage by CRISPR-Cas12a journal July 2018
Directed evolution of CRISPR-Cas9 to increase its specificity journal August 2018
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines journal June 2021
Multiplexed genome regulation in vivo with hyper-efficient Cas12a journal April 2022
Structural biology of CRISPR–Cas immunity and genome editing enzymes journal May 2022
Highly accurate protein structure prediction with AlphaFold journal July 2021
Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing journal February 2019
CRISPR–Cas12-based detection of SARS-CoV-2 journal April 2020
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells journal August 2018
In vivo profiling of metastatic double knockouts through CRISPR–Cpf1 screens journal April 2019
Making the cut(s): how Cas12a cleaves target and non-target DNA journal October 2019
Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases journal February 2020
Decoupling the bridge helix of Cas12a results in a reduced trimming activity, increased mismatch sensitivity and impaired conformational transitions journal May 2021
Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain journal September 2022
A highly sensitive selection method for directed evolution of homing endonucleases journal October 2005
Engineering CRISPR/ Lb Cas12a for highly efficient, temperature‐tolerant plant gene editing journal May 2020
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 journal February 2018
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity journal February 2018
CRISPR-Cas guides the future of genetic engineering journal August 2018
CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems journal October 2015
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity journal April 2022
Genome Editing for CNS Disorders journal October 2020
CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks journal June 2020

Similar Records

CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA
Journal Article · Sat Jul 16 00:00:00 EDT 2022 · Scientific Reports · OSTI ID:1876454

Directed evolution expands CRISPR–Cas12a genome-editing capacity
Journal Article · Tue Jul 08 00:00:00 EDT 2025 · Nucleic Acids Research (NAR) · OSTI ID:2583302

Related Subjects